Literature DB >> 29997232

Normal Breast-Derived Epithelial Cells with Luminal and Intrinsic Subtype-Enriched Gene Expression Document Interindividual Differences in Their Differentiation Cascade.

Brijesh Kumar1, Mayuri Prasad1, Poornima Bhat-Nakshatri1, Manjushree Anjanappa1, Maitri Kalra2, Natascia Marino2, Anna Maria Storniolo2, Xi Rao3, Sheng Liu3, Jun Wan3, Yunlong Liu3, Harikrishna Nakshatri4,5,6.   

Abstract

Cell-type origin is one of the factors that determine molecular features of tumors, but resources to validate this concept are scarce because of technical difficulties in propagating major cell types of adult organs. Previous attempts to generate such resources to study breast cancer have yielded predominantly basal-type cell lines. We have created a panel of immortalized cell lines from core breast biopsies of ancestry-mapped healthy women that form ductal structures similar to normal breast in 3D cultures and expressed markers of major cell types, including the luminal-differentiated cell-enriched ERα-FOXA1-GATA3 transcription factor network. We have also created cell lines from PROCR (CD201)+/EpCAM- cells that are likely the "normal" counterpart of the claudin-low subtype of breast cancers. RNA-seq and PAM50-intrinsic subtype clustering identified these cell lines as the "normal" counterparts of luminal A, basal, and normal-like subtypes and validated via immunostaining with basal-enriched KRT14 and luminal-enriched KRT19. We further characterized these cell lines by flow cytometry for distribution patterns of stem/basal, luminal-progenitor, mature/differentiated, multipotent PROCR+ cells, and organogenesis-enriched epithelial/mesenchymal hybrid cells using CD44/CD24, CD49f/EpCAM, CD271/EpCAM, CD201/EpCAM, and ALDEFLUOR assays and E-cadherin/vimentin double staining. These cell lines showed interindividual heterogeneity in stemness/differentiation capabilities and baseline activity of signaling molecules such as NF-κB, AKT2, pERK, and BRD4. These resources can be used to test the emerging concept that genetic variations in regulatory regions contribute to widespread differences in gene expression in "normal" conditions among the general population and can delineate the impact of cell-type origin on tumor progression.Significance: In addition to providing a valuable resource for the breast cancer research community to investigate cell-type origin of different subtypes of breast cancer, this study highlights interindividual differences in normal breast, emphasizing the need to use "normal" cells from multiple sources as controls to decipher the effects of cancer-specific genomic aberrations. Cancer Res; 78(17); 5107-23. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29997232      PMCID: PMC6125218          DOI: 10.1158/0008-5472.CAN-18-0509

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  65 in total

1.  Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.

Authors:  Brian D Lehmann; Joshua A Bauer; Xi Chen; Melinda E Sanders; A Bapsi Chakravarthy; Yu Shyr; Jennifer A Pietenpol
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

Review 2.  Molecular pathways: targeting p21-activated kinase 1 signaling in cancer--opportunities, challenges, and limitations.

Authors:  Jeyanthy Eswaran; Da-Qiang Li; Anil Shah; Rakesh Kumar
Journal:  Clin Cancer Res       Date:  2012-05-17       Impact factor: 12.531

3.  Mammary development meets cancer genomics.

Authors:  Aleix Prat; Charles M Perou
Journal:  Nat Med       Date:  2009-08       Impact factor: 53.440

Review 4.  Advances in the treatment of advanced oestrogen-receptor-positive breast cancer.

Authors:  Nicholas C Turner; Patrick Neven; Sibylle Loibl; Fabrice Andre
Journal:  Lancet       Date:  2016-12-07       Impact factor: 79.321

Review 5.  Pleiotropic Roles for ZEB1 in Cancer.

Authors:  Julie Caramel; Maud Ligier; Alain Puisieux
Journal:  Cancer Res       Date:  2017-12-18       Impact factor: 12.701

6.  A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability.

Authors:  Anne-Pierre Morel; Christophe Ginestier; Roxane M Pommier; Olivier Cabaud; Emmanuelle Ruiz; Julien Wicinski; Mojgan Devouassoux-Shisheboran; Valérie Combaret; Pascal Finetti; Christelle Chassot; Christiane Pinatel; Frédérique Fauvet; Pierre Saintigny; Emilie Thomas; Caroline Moyret-Lalle; Joël Lachuer; Emmanuelle Despras; Jean-Luc Jauffret; François Bertucci; Jérôme Guitton; Anne Wierinckx; Qing Wang; Nina Radosevic-Robin; Frédérique Penault-Llorca; David G Cox; Frédéric Hollande; Stéphane Ansieau; Julie Caramel; Daniel Birnbaum; Arnaud M Vigneron; Agnès Tissier; Emmanuelle Charafe-Jauffret; Alain Puisieux
Journal:  Nat Med       Date:  2017-04-10       Impact factor: 53.440

7.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.

Authors:  Mark D Robinson; Davis J McCarthy; Gordon K Smyth
Journal:  Bioinformatics       Date:  2009-11-11       Impact factor: 6.937

8.  Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes.

Authors:  Aleix Prat; Olga Karginova; Joel S Parker; Cheng Fan; Xiaping He; Lisa Bixby; J Chuck Harrell; Erick Roman; Barbara Adamo; Melissa Troester; Charles M Perou
Journal:  Breast Cancer Res Treat       Date:  2013-10-27       Impact factor: 4.872

9.  DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer.

Authors:  Andrew E Teschendorff; Yang Gao; Allison Jones; Matthias Ruebner; Matthias W Beckmann; David L Wachter; Peter A Fasching; Martin Widschwendter
Journal:  Nat Commun       Date:  2016-01-29       Impact factor: 14.919

10.  Proof of region-specific multipotent progenitors in human breast epithelia.

Authors:  Agla J Fridriksdottir; René Villadsen; Mikkel Morsing; Marie Christine Klitgaard; Jiyoung Kim; Ole William Petersen; Lone Rønnov-Jessen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-06       Impact factor: 11.205

View more
  22 in total

1.  Dual TGFβ/BMP Pathway Inhibition Enables Expansion and Characterization of Multiple Epithelial Cell Types of the Normal and Cancerous Breast.

Authors:  Mayuri Prasad; Brijesh Kumar; Poornima Bhat-Nakshatri; Manjushree Anjanappa; George Sandusky; Kathy D Miller; Anna Maria Storniolo; Harikrishna Nakshatri
Journal:  Mol Cancer Res       Date:  2019-04-16       Impact factor: 5.852

2.  Single-cell analysis reveals the Comma-1D cell line as a unique model for mammary gland development and breast cancer.

Authors:  Rachel L Werner; Erin A Nekritz; Koon-Kiu Yan; Bensheng Ju; Bridget Shaner; John Easton; Jiyang Yu; Jose Silva
Journal:  J Cell Sci       Date:  2022-05-20       Impact factor: 5.235

Review 3.  Environmental exposures, stem cells, and cancer.

Authors:  Tasha Thong; Chanese A Forté; Evan M Hill; Justin A Colacino
Journal:  Pharmacol Ther       Date:  2019-07-31       Impact factor: 12.310

4.  Breast Cancer Cell Detection and Characterization from Breast Milk-Derived Cells.

Authors:  Poornima Bhat-Nakshatri; Brijesh Kumar; Ed Simpson; Kandice K Ludwig; Mary L Cox; Hongyu Gao; Yunlong Liu; Harikrishna Nakshatri
Journal:  Cancer Res       Date:  2020-09-15       Impact factor: 12.701

5.  Aging-associated skeletal muscle defects in HER2/Neu transgenic mammary tumor model.

Authors:  Ruizhong Wang; Brijesh Kumar; Poornima Bhat-Nakshatri; Mayuri S Prasad; Max H Jacobsen; Gabriela Ovalle; Calli Maguire; George Sandusky; Trupti Trivedi; Khalid S Mohammad; Theresa Guise; Narsimha R Penthala; Peter A Crooks; Jianguo Liu; Teresa Zimmers; Harikrishna Nakshatri
Journal:  JCSM Rapid Commun       Date:  2020-07-15

6.  Death effector domain-containing protein induces vulnerability to cell cycle inhibition in triple-negative breast cancer.

Authors:  Yingjia Ni; Keon R Schmidt; Barnes A Werner; Jenna K Koenig; Ian H Guldner; Patricia M Schnepp; Xuejuan Tan; Lan Jiang; Misha Host; Longhua Sun; Erin N Howe; Junmin Wu; Laurie E Littlepage; Harikrishna Nakshatri; Siyuan Zhang
Journal:  Nat Commun       Date:  2019-06-28       Impact factor: 14.919

7.  Bidirectional Regulatory Cross-Talk between Cell Context and Genomic Aberrations Shapes Breast Tumorigenesis.

Authors:  Brijesh Kumar; Poornima Bhat-Nakshatri; Calli Maguire; Max Jacobsen; Constance J Temm; George Sandusky; Harikrishna Nakshatri
Journal:  Mol Cancer Res       Date:  2021-07-20       Impact factor: 5.852

8.  Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages.

Authors:  Jennifer M Rosenbluth; Ron C J Schackmann; G Kenneth Gray; Laura M Selfors; Carman Man-Chung Li; Mackenzie Boedicker; Hendrik J Kuiken; Andrea Richardson; Jane Brock; Judy Garber; Deborah Dillon; Norman Sachs; Hans Clevers; Joan S Brugge
Journal:  Nat Commun       Date:  2020-04-06       Impact factor: 14.919

9.  Specific chromatin landscapes and transcription factors couple breast cancer subtype with metastatic relapse to lung or brain.

Authors:  Wesley L Cai; Celeste B Greer; Jocelyn F Chen; Anna Arnal-Estapé; Jian Cao; Qin Yan; Don X Nguyen
Journal:  BMC Med Genomics       Date:  2020-03-06       Impact factor: 3.063

10.  High-throughput surface marker screen on primary human breast tissues reveals further cellular heterogeneity.

Authors:  Siru Virtanen; Reiner Schulte; John Stingl; Carlos Caldas; Mona Shehata
Journal:  Breast Cancer Res       Date:  2021-06-13       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.